Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
about
Parallel Aspects of the Microenvironment in Cancer and Autoimmune DiseaseTargeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cellsDoxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient PrognosisTumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer.Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian CancerCCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinomaCCL2/EGF positive feedback loop between cancer cells and macrophages promotes cell migration and invasion in head and neck squamous cell carcinoma.The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2.Tumour-associated macrophages as treatment targets in oncology.Tumor regulation of the tissue environment in the liver.Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.Liver macrophages in tissue homeostasis and disease.Barriers to Radiation-Induced In Situ Tumor Vaccination.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Transcriptome-Wide Analysis Reveals Modulation of Human Macrophage Inflammatory Phenotype Through Alternative Splicing.IRE1α inhibition by natural compound genipin on tumour associated macrophages reduces growth of hepatocellular carcinoma.Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages.A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer.Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.Inhibition of KPNA4 attenuates prostate cancer metastasis.Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression.Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges.Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines.CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.Selective targeting of tumor associated macrophages in different tumor models.Nonresolving macrophage-mediated inflammation in malignancy.Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma.Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma.Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma.CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer.Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages.
P2860
Q26753174-03ED3533-47E0-49FF-B57B-98AB2A7061F4Q33889144-CF64E6E0-DD24-47F4-A006-683FFB7AE11AQ36274684-9B5EB5D7-722B-49E5-9C57-18237BE6492BQ36322143-6C99B15A-5BC6-46CB-A039-E5C079A7828CQ36743574-D6ED8F17-2246-4255-ABB7-3CC6EE8DF2A1Q36984367-DAC51D06-57D9-474E-8F3C-0FC31837D0B4Q37510221-C57E9FD4-6964-4350-8AA5-9078C20EBB30Q37588317-022FB2B6-0A5A-4B0D-9D94-20AC88FED804Q37699365-1BD02F04-CE4E-410B-A03D-450E49FCAA19Q38675589-BB88D765-1E34-40A3-AECF-4AEF99B1DD0CQ38726039-F944AF67-6178-4B3B-BEA0-067363C2CC93Q38754114-75337B29-8AE3-4129-8305-F61036B01438Q39100693-1BF0AEBD-69B6-4F48-B0B5-573DE680737AQ39123136-7DFA3FE4-52AE-44BE-BC9B-3867AC4E7B79Q39144794-41661499-8845-4512-AB20-EA9DE3A81E8FQ39187324-9FDEAF77-269E-4C63-99C5-DBD2E6FCF010Q39203685-D3931B8C-20F5-4AC2-A4F2-9761B9B631A3Q39358916-0787A4F4-CBB6-4071-B269-D529FFB10137Q39733187-AAEE5E98-1B6F-454D-854B-7CFCD6D933D3Q39986343-8D911461-BAF6-41B3-8A10-D4405B9BB355Q41071492-A2926D92-6B65-4E1E-93B4-A52338FA478AQ41338881-4C673229-4A5D-4FEC-AEF8-F9A2A026D1BAQ41348794-586F1E33-6580-4D9F-9152-F9F47BEA2444Q41858851-BB2077E2-774A-44F6-8922-5D551B8A4167Q46797418-B7BF053F-F7DC-40BB-919D-3B01F3DDA0D2Q47739102-47FBEC98-3D16-4718-B546-974F1321351AQ48290538-BF263A59-5C88-4873-8E2C-68F3208EB674Q49185880-61E0B13E-6390-4B67-A79C-214F65B351B1Q49187592-AE9CC11B-A204-4A48-B00C-D5482E4A63BBQ49979720-D18AD898-6488-465C-8B8C-4D90998BD862Q50249667-7B87B619-BD8F-4ECA-B513-F6374DB2F1E6Q52672848-65ED9651-42AF-4FFD-8DF6-11DEB973A628Q52673026-E95E36F9-CB2A-469E-812B-30AC4F6EE734Q52699879-79CA71CE-87BB-4236-8B49-F9E2106AC32FQ53064219-B63BD4C4-A384-4C0F-ABBD-53A72A350DF1Q53099163-5CE5675B-FB18-456C-A7E3-14556D7D1D63Q55012882-DE88E93D-B0AB-417D-B98E-5AA950E26962Q55127228-F05BEBF8-F30F-4102-8B3A-0BCC02883A78Q55513244-D98D867B-3D32-4844-8910-A7362429EA1FQ55518185-7B81E35D-EAD6-49FC-A625-30B1B9C93BAF
P2860
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting of tumour-infiltrati ...... inst hepatocellular carcinoma.
@en
type
label
Targeting of tumour-infiltrati ...... inst hepatocellular carcinoma.
@en
prefLabel
Targeting of tumour-infiltrati ...... inst hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Targeting of tumour-infiltrati ...... inst hepatocellular carcinoma.
@en
P2093
Haiyun Song
Jingquan Li
Peizhan Chen
Xiaoguang Li
Xiaoqing Jiang
P2860
P304
P356
10.1136/GUTJNL-2015-310514
P407
P577
2015-10-09T00:00:00Z